# PraxbindTM India PMS Program

> **NCT03359889** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 5 (actual)

## Conditions studied

- Thromboembolism

## Interventions

- **DRUG:** PraxbindTM

## Key facts

- **NCT ID:** NCT03359889
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-26
- **Primary completion:** 2020-01-13
- **Final completion:** 2020-01-13
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359889, "PraxbindTM India PMS Program". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03359889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*